Clinical trial
Head-to-Head Comparison of Hepatocellular Cancer (HCC) Screening Strategies: A Prospective Population-Based Cohort Study in Zhongshan City
NCT07010198 is registered in ClinicalTrials.gov with Zhongshan People's Hospital, Guangdong, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Head-to-Head Comparison of Hepatocellular Cancer (HCC) Screening Strategies: A Prospective Population-Based Cohort Study in Zhongshan City
- Lead sponsor
- Zhongshan People's Hospital, Guangdong, China
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 1, 2025
- Completion date
- December 31, 2028
- Enrollment
- 4,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular cancer (hcc)